US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices

US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices

FT.com

Published

Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high

Full Article